Teslake

Teslake

Early Stage

Solving the biggest problems in spinal deformity surgeries

Solving the biggest problems in spinal deformity surgeries

Overview

Raised to Date: Raised: $41,672

Total Commitments ($USD)

Platform

Dealmaker Securities

Start Date

08/28/2023

Close Date

04/29/2024

Min. Goal
$25,225
Max. Goal
$1,234,653
Min. Investment

$101

Security Type

Equity - Common

Series

Series A

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$50.45

Pre-Money Valuation

$30,910,768

Rolling Commitments ($USD)

Status
Funded
Reporting Date

05/04/2024

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$171

# of Investors

15

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2019

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B2C

Margin

High

Capital Intensity

High

Location

San Diego, California

Business Type

Growth

Teslake is raising funds on Dealmaker. The company is solving the biggest problems in spinal deformity surgeries with robotics and a proprietary microbe-eradicating metal alloy. Their system combines state-of-the-art implants, their proprietary Guardinium™ Alloy, and a synchronized team of mini robots to make spinal deformity surgeries more predictable and easier. Thousands of implants are already in use, and with seven FDA-approved products and three patents filed, they are revenue positive. Stephen Foti, CEO, and Lukas Eisermann, President incorporated the business in 2019. The current crowdfunding campaign has a minimum target of $1,009 and a maximum target of $1.23 million. The campaign proceeds will be used for spine implants/instrument inventory, Guardinium Alloy instruments, SMR second generation, working capital, accounting, marketing & advertising, and intermediary fees.

Summary Profit and Loss Statement

FY 2022 FY 2021

Revenue

$868,427

$368,602

COGS

$41,253

$23,706

Tax

$0

$0

 

 

Net Income

$-182,618

$-264,514

Summary Balance Sheet

FY 2022 FY 2021

Cash

$82,470

$662,833

Accounts Receivable

$100,100

$40,049

Total Assets

$1,617,249

$1,626,876

Short-Term Debt

$443,021

$268,855

Long-Term Debt

$2,777,387

$2,776,071

Total Liabilities

$3,220,408

$3,044,926

Financials as of: 08/28/2023
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Teslake on Dealmaker Securities 2023
Platform: Dealmaker Securities
Security Type: Equity - Common
Valuation: $30,910,768
Price per Share: $50.45

Follow company

Follow Teslake on Dealmaker Securities 2023

Buy Teslake's Deal Report

Warning: according to the close date for this deal, Teslake may no longer be accepting investments.

Teslake Deal Report

Get KingsCrowd’s comprehensive report on Teslake including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Teslake is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Teslake deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge